# OnCo record hormone-therapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/hormone-therapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "hormone-therapy" ;
  schema:name "Hormone therapy"@en ;
  schema:alternateName "hormone therapies"@en, "hormonal therapy"@en, "hormonal therapies"@en, "endocrine therapy"@en, "endocrine therapies"@en, "anti-hormone"@en, "antihormonal"@en, "hormone-sensitive"@en, "hormone sensitive"@en, "hormone-driven"@en, "hormone receptor"@en, "hormone receptors"@en, "hormone-receptor positive"@en, "hormone receptor positive"@en, "hormone-receptor-positive"@en, "HR-positive"@en, "HR+"@en, "castration"@en, "castration-resistant"@en, "castration-sensitive"@en ;
  schema:description "Treatment that starves cancers which grow in response to a hormone, mainly oestrogen in breast cancer and testosterone in prostate cancer, by lowering the hormone or blocking its receptor."@en ;
  schema:url <https://onco.cc/terms/hormone-therapy/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hormonal_therapy_(oncology)> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5903784> ;
  schema:citation <https://en.wikipedia.org/wiki/Hormonal_therapy_(oncology)> ;
  onco:related <https://onco.cc/terms/receptor/>, <https://onco.cc/terms/agonist-antagonist/>, <https://onco.cc/terms/targeted-therapy-term/>, <https://onco.cc/terms/resistance/>, <https://onco.cc/terms/maintenance-therapy/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/>, <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/>, <https://onco.cc/targets/androgen-receptor/>, <https://onco.cc/targets/cdk4-6/> ;
  onco:drugs <https://onco.cc/drugs/elacestrant/>, <https://onco.cc/drugs/vepdegestrant/>, <https://onco.cc/drugs/palbociclib/> ;
  onco:pathways <https://onco.cc/pathways/er-signaling/>, <https://onco.cc/pathways/ar-signaling/> .